DE68904336T2 - Anti-humankrebsproteinkomplexe, deren herstellung und verwendung. - Google Patents
Anti-humankrebsproteinkomplexe, deren herstellung und verwendung.Info
- Publication number
- DE68904336T2 DE68904336T2 DE8989106024T DE68904336T DE68904336T2 DE 68904336 T2 DE68904336 T2 DE 68904336T2 DE 8989106024 T DE8989106024 T DE 8989106024T DE 68904336 T DE68904336 T DE 68904336T DE 68904336 T2 DE68904336 T2 DE 68904336T2
- Authority
- DE
- Germany
- Prior art keywords
- production
- human cancer
- protein complexes
- cancer protein
- complexes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/44—Antibodies bound to carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6829—Bacterial toxins, e.g. diphteria toxins or Pseudomonas exotoxin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6875—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody being a hybrid immunoglobulin
- A61K47/6879—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody being a hybrid immunoglobulin the immunoglobulin having two or more different antigen-binding sites, e.g. bispecific or multispecific immunoglobulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8784588 | 1988-04-08 | ||
JP1041323A JPH02196799A (ja) | 1988-04-08 | 1989-02-21 | 抗ヒト癌蛋白複合体 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE68904336D1 DE68904336D1 (de) | 1993-02-25 |
DE68904336T2 true DE68904336T2 (de) | 1993-05-19 |
Family
ID=26380909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8989106024T Expired - Lifetime DE68904336T2 (de) | 1988-04-08 | 1989-04-06 | Anti-humankrebsproteinkomplexe, deren herstellung und verwendung. |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0336405B1 (de) |
JP (1) | JPH02196799A (de) |
KR (1) | KR890015753A (de) |
DE (1) | DE68904336T2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8907310D0 (en) * | 1989-03-31 | 1989-05-17 | Medical Res Council | Heteroconjugates |
ES2094231T3 (es) * | 1990-07-20 | 1997-01-16 | Pharmacia & Upjohn Ab | Conjugados de anticuerpos superantigenos especificos de una diana y su preparacion. |
SE9002484L (sv) | 1990-07-20 | 1992-01-21 | Kabi Pharmacia Ab | Nya substituerade polyetrar |
US5858363A (en) * | 1990-07-20 | 1999-01-12 | Pharmacia & Upjohn Ab | Target specific antibody-superantigen conjugates and their preparation |
US6582053B1 (en) | 1998-02-18 | 2003-06-24 | Canon Kabushiki Kaisha | Method for manufacturing a liquid jet recording head and a liquid jet recording head manufactured by such method |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES8504461A1 (es) * | 1982-04-12 | 1985-04-16 | Hybritech Inc | Un procedimiento para obtener un polidoma. |
US4545985A (en) * | 1984-01-26 | 1985-10-08 | The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services | Pseudomonas exotoxin conjugate immunotoxins |
US4689311A (en) * | 1985-09-30 | 1987-08-25 | Rhode Island Hospital | Screening antibodies for capacity to deliver toxin to target cells |
US4806494A (en) * | 1986-07-24 | 1989-02-21 | The United States Of America As Represented By The Department Of Health & Human Services | Monoclonal antibody against ovarian cancer cells (OVB-3) |
JPS6463374A (en) * | 1987-09-03 | 1989-03-09 | Agency Ind Science Techn | Human monoclonal antibody, antibody-forming cell, antibody-forming hybridoma and production of antibody |
-
1989
- 1989-02-21 JP JP1041323A patent/JPH02196799A/ja active Pending
- 1989-04-06 DE DE8989106024T patent/DE68904336T2/de not_active Expired - Lifetime
- 1989-04-06 EP EP89106024A patent/EP0336405B1/de not_active Expired - Lifetime
- 1989-04-08 KR KR1019890004668A patent/KR890015753A/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0336405A3 (en) | 1990-05-30 |
EP0336405B1 (de) | 1993-01-13 |
KR890015753A (ko) | 1989-11-25 |
JPH02196799A (ja) | 1990-08-03 |
EP0336405A2 (de) | 1989-10-11 |
DE68904336D1 (de) | 1993-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68924026D1 (de) | Biosensor und dessen herstellung. | |
DE3682654D1 (de) | Acylaminosiliciumverbindungen, deren verwendung und herstellung. | |
ATE111452T1 (de) | Tetrahydronaphthalin- und indanderivate, deren herstellung und verwendung für pharmazeutische präparate. | |
DE3581578D1 (de) | Antikoerper, herstellung und verwendung. | |
DE3674089D1 (de) | Thiazolidin-derivate, deren herstellung und verwendung. | |
DE3667998D1 (de) | Reaktivfarbstoffe, deren herstellung und verwendung. | |
DE3668326D1 (de) | Reaktivfarbstoffe, deren herstellung und verwendung. | |
DE3887194T2 (de) | Antitumor-Platinkomplexe, deren Herstellung und deren therapeutische Verwendung. | |
DE3669323D1 (de) | Reaktivfarbstoffe, deren herstellung und verwendung. | |
DE3484531D1 (de) | Tetrahydrobenzotriazole, deren herstellung und verwendung. | |
DE3889980D1 (de) | Reaktivfarbstoffe, deren Herstellung und Verwendung. | |
DE3673474D1 (de) | Reaktivfarbstoffe, deren herstellung und verwendung. | |
DE68900210D1 (de) | Pyranobenzoxadiazolderivate, herstellung, verwendung und diese enthaltende zubereitungen. | |
DE3669518D1 (de) | Vollaromatische polyester, deren herstellung und verwendung. | |
DE3886382D1 (de) | Wärmestabiles cyclodextrin glycosyl-transferase, deren herstellung und verwendung. | |
DE3867859D1 (de) | Schwermetallkomplexfarbstoffe, deren herstellung und verwendung. | |
DE3583296D1 (de) | Oncofetal spezifische monoklonale antikoerper, deren herstellung und verwendung. | |
DE3789352D1 (de) | Neue biphenylabkömmlinge, deren herstellung und verwendung. | |
DE68904336D1 (de) | Anti-humankrebsproteinkomplexe, deren herstellung und verwendung. | |
DE68908389D1 (de) | Amidofluoroverbindungen, ihre herstellung und ihre verwendung. | |
DE3685743D1 (de) | Anthracyclinderivate, ihre verwendung als antitumorsubstanzen und ihre herstellung. | |
DE68919259D1 (de) | N-Phenylimide, ihre Herstellung und Verwendung. | |
DE3872337D1 (de) | Reaktivfarbstoffe, deren herstellung und verwendung. | |
DE3862766D1 (de) | Reaktivfarbstoffe, deren herstellung und verwendung. | |
DE3868287D1 (de) | Reaktivfarbstoffe, deren herstellung und verwendung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |